Non-syndromic anorectal malformation
ORPHA:557Clinical groupAntenatal, Neonatal
Эпидемиология21
| Тип оценки | Класс распространённости | Среднее (на 100к) | Регион | Квалификация |
|---|---|---|---|---|
| Prevalence at birth | 1-5 / 10 000 | 20 | Worldwide | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 24 | Europe | Value and class |
| Prevalence at birth | 6-9 / 10 000 | 78 | Austria | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 26.2 | Belgium | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 11.4 | Croatia | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 21.3 | Denmark | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 23.6 | France | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 53.5 | Germany | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 43.2 | Hungary | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 28.9 | Ireland | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 11.3 | Italy | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 29.2 | Netherlands | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 29.5 | Norway | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 11.6 | Poland | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 4.7 | Portugal | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 13.8 | Spain | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 49 | Switzerland | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 21.6 | United Kingdom | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 28.6 | Ukraine | Value and class |
| Prevalence at birth | 6-9 / 10 000 | 60.8 | Saudi Arabia | Value and class |
| Point prevalence | 1-5 / 10 000 | — | Europe | Class only |
Лекарства и терапия
Источник: Open Targets Platform (в реальном времени)
Клинические исследования
Источник: ClinicalTrials.gov (в реальном времени)